Regional and systemic hemodynamic responses following the creation of a murine arteriovenous fistula

American Journal of Physiology - Renal Physiology

Volumn 301, Issue 4, 2011, Pages

  Kang, Lu ^a   Yamada, Satsuki ^a   Hernandez, Melissa C ^a   Croatt, Anthony J ^a   Grande, Joseph P ^a   Juncos, Julio P ^a   Vercellotti, Gregory M ^a   Hebbel, Robert P ^a   Katusic, Zvonimir S ^b   Terzic, Andre ^a   Nath, Karl A ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Heme oxygenase 1; Shear stress; Sickle cell disease; Vascular access dysfunction; Vascular adaptation

Indexed keywords

ACETYLCHOLINE; HEME OXYGENASE 1; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD RHEOLOGY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART OUTPUT; HEMODYNAMIC STRESS; KIDNEY ARTERIOVENOUS FISTULA; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SICKLE CELL ANEMIA; SMOOTH MUSCLE FIBER; VASODILATATION; WILD TYPE;

EID: 80053341150     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00311.2011     Document Type: Article

References (38)

1. Abbott KC, Hypolite IO, Agodoa LY. Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol 58: 9-15, 2002.
2. Allon M. Current management of vascular access. Clin J Am Soc Nephrol 2: 786-800, 2007.
3. Belhassen L, Pelle G, Sediame S, Bachir D, Carville C, Bucherer C, Lacombe C, Galacteros F, Adnot S. Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stressmediated vasodilation. Blood 97: 1584-1589, 2001.
4. Ben Driss A, Benessiano J, Poitevin P, Levy BI, Michel JB. Arterial expansive remodeling induced by high flow rates. Am J Physiol Heart Circ Physiol 272: H851-H858, 1997.
5. Boerrigter G, Burnett JC Jr. Cardiorenal syndrome in decompensated heart failure: prognostic and therapeutic implications. Curr Heart Fail Rep 1: 113-120, 2004.
6. Castier Y, Brandes RP, Leseche G, Tedgui A, Lehoux S. p47phoxdependent NADPH oxidase regulates flow-induced vascular remodeling. Circ Res 97: 533-540, 2005.
7. Castier Y, Lehoux S, Hu Y, Foteinos G, Tedgui A, Xu Q. Characterization of neointima lesions associated with arteriovenous fistulas in a mouse model. Kidney Int 70: 315-320, 2006.
8. Croatt AJ, Grande JP, Hernandez MC, Ackerman AW, Katusic ZS, Nath KA. Characterization of a model of an arteriovenous fistula in the rat: the effect of L-NAME. Am J Pathol 176: 2530-2541, 2010.
9. Dixon BS. Why don't fistulas mature? Kidney Int 70: 1413-1422, 2006.
10. Dulak J, Deshane J, Jozkowicz A, Agarwal A. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 117: 231-241, 2008.
11. Hebbel RP, Vercellotti G, Nath KA. A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis. Cardiovasc Hematol Disord Drug Targets 9: 271-292, 2009.
12. Hill-Kapturczak N, Agarwal A. Haem oxygenase-1-a culprit in vascular and renal damage? Nephrol Dial Transplant 22: 1495-1499, 2007.
13. Iadecola C, Zhang F, Niwa K, Eckman C, Turner SK, Fischer E, Younkin S, Borchelt DR, Hsiao KK, Carlson GA. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci 2: 157-161, 1999.
14. Juncos JP, Grande JP, Croatt AJ, Hebbel RP, Vercellotti GM, Katusic ZS, Nath KA. Early and prominent alterations in hemodynamics, signaling, and gene expression following renal ischemia in sickle cell disease. Am J Physiol Renal Physiol 298: F892-F899, 2010.
15. Juncos JP, Grande JP, Kang L, Ackerman AW, Croatt AJ, Katusic ZS, Nath KA. MCP-1 contributes to arteriovenous fistula failure. J Am Soc Nephrol 22: 43-48, 2010.
16. Juncos JP, Grande JP, Murali N, Croatt AJ, Juncos LA, Hebbel RP, Katusic ZS, Nath KA. Anomalous renal effects of tin protoporphyrin in a murine model of sickle cell disease. Am J Pathol 169: 21-31, 2006.
17. Juncos JP, Tracz MJ, Croatt AJ, Grande JP, Ackerman AW, Katusic ZS, Nath KA. Genetic deficiency of heme oxygenase-1 impairs functionality and form of an arteriovenous fistula in the mouse. Kidney Int 74: 47-51, 2008.
18. Kamiya A, Togawa T. Adaptive regulation of wall shear stress to flow change in the canine carotid artery. Am J Physiol Heart Circ Physiol 239: H14-H21, 1980.
19. Kanwar YS. Functional duality of progenitor cells influxing into arteriovenous fistula during its neoangiogenesis. Am J Physiol Renal Physiol 293: F468-F469, 2007.
20. Michel F, Duriez M, Levy BI, Boulanger CM. Minimally invasive, in vivo exploration of mouse small artery reactivity. J Cardiovasc Pharmacol 43: 271-275, 2004.
21. Nath KA. Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int 70: 432-443, 2006.
22. Nath KA, Grande JP, Croatt AJ, Frank E, Caplice NM, Hebbel RP, Katusic ZS. Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury. Am J Pathol 166: 963-972, 2005.
23. Nath KA, Grande JP, Haggard JJ, Croatt AJ, Katusic ZS, Solovey A, Hebbel RP. Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am J Pathol 158: 893-903, 2001.
24. Nath KA, Grande JP, Kang L, Juncos JP, Ackerman AW, Croatt AJ, Katusic ZS. β-Catenin is markedly induced in a murine model of an arteriovenous fistula: the effect of metalloproteinase inhibition. Am J Physiol Renal Physiol 299: F1270-F1277, 2010.
25. Nath KA, Katusic ZS, Gladwin MT. The perfusion paradox and vascular instability in sickle cell disease. Microcirculation 11: 179-193, 2004.
26. Nath KA, Shah V, Haggard JJ, Croatt AJ, Smith LA, Hebbel RP, Katusic ZS. Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. Am J Physiol Regul Integr Comp Physiol 279: R1949-R1955, 2000.
27. Ojo AO, Govaerts TC, Schmouder RL, Leichtman AB, Leavey SF, Wolfe RA, Held PJ, Port FK, Agodoa LY. Renal transplantation in end-stage sickle cell nephropathy. Transplantation 67: 291-295, 1999.
28. Pittock ST, Norby SM, Grande JP, Croatt AJ, Bren GD, Badley AD, Caplice NM, Griffin MD, Nath KA. MCP-1 is upregulated in unstressed and stressed HO-1 knockout mice: pathophysiologic correlates. Kidney Int 68: 611-622, 2005.
29. Poss KD, Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 94: 10919-10924, 1997.
30. Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, Johnson C. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med 115: 614-620, 1991.
31. Santoro D, Savica V, Bellinghieri G. Vascular access for hemodialysis and cardiovascular complications. Minerva Urol Nefrol 62: 81-85, 2010.
32. Schinstock C, Albright R, Williams A, Dillon J, Bergstralh E, Jenson B, McCarthy J, Nath KA. Outcomes of arteriovenous fistula creation after the fistula first initiative. Clin J Am Soc Nephrol In press.
33. Stern AB, Klemmer PJ. High-output heart failure secondary to arteriovenous fistula. Hemodial Int In press.
34. Tracz MJ, Juncos JP, Croatt AJ, Ackerman AW, Grande JP, Knutson KL, Kane GC, Terzic A, Griffin MD, Nath KA. Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia. Kidney Int 72: 1073-1080, 2007.
35. Tracz MJ, Juncos JP, Grande JP, Croatt AJ, Ackerman AW, Rajagopalan G, Knutson KL, Badley AD, Griffin MD, Alam J, Nath KA. Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/-mice. Am J Pathol 170: 1820-1830, 2007.
36. Yamada S, Kane GC, Behfar A, Liu XK, Dyer RB, Faustino RS, Miki T, Seino S, Terzic A. Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant. J Physiol 577: 1053-1065, 2006.
37. Yamada S, Nelson TJ, Behfar A, Crespo-Diaz RJ, Fraidenraich D, Terzic A. Stem cell transplant into preimplantation embryo yields myocardial infarction-resistant adult phenotype. Stem Cells 27: 1697-1705, 2009.
38. Yamada S, Nelson TJ, Crespo-Diaz RJ, Perez-Terzic C, Liu XK, Miki T, Seino S, Behfar A, Terzic A. Embryonic stem cell therapy of heart failure in genetic cardiomyopathy. Stem Cells 26: 2644-2653, 2008.